IL-13 R alpha 2

IL-13 R alpha 2 詳細

英語名Interleukin-13 receptor subunit alpha-2市販薬剤の数0
治験薬の数9ターゲットの別称Interleukin 13 Receptor Alpha 2 Chain,Interleukin-13 Receptor alpha2 Subunit,IL-13RA2,IL-13R-alpha-2,Interleukin-13-binding protein,IL13RA2,Interleukin 13 Receptor Subunit Alpha 2,Interleukin 13 Receptor, Alpha 2,IL-13 Receptor Subunit Alpha-2,Cancer/Testis Antigen 19,IL-13R Subunit Alpha-2,Interleukin-13 Receptor Subunit Alpha-2,Interleukin 13 Binding Protein,CD213a2 Antigen,CD213A2,IL-13R,IL13BP,IL13R,CT19
研究&開発段階Phase 1 Clinical
英語名Interleukin-13 receptor subunit alpha-2
ターゲットの別称Interleukin 13 Receptor Alpha 2 Chain,Interleukin-13 Receptor alpha2 Subunit,IL-13RA2,IL-13R-alpha-2,Interleukin-13-binding protein,IL13RA2,Interleukin 13 Receptor Subunit Alpha 2,Interleukin 13 Receptor, Alpha 2,IL-13 Receptor Subunit Alpha-2,Cancer/Testis Antigen 19,IL-13R Subunit Alpha-2,Interleukin-13 Receptor Subunit Alpha-2,Interleukin 13 Binding Protein,CD213a2 Antigen,CD213A2,IL-13R,IL13BP,IL13R,CT19
市販薬剤の数0
治験薬の数9
研究&開発段階Phase 1 Clinical

IL-13 R alpha 2 製品リスト

  • 属性

    Protein (8)

  • 製品ライブラリ

    オンライン (8)

  • Human (4)Rhesus macaque (1)Canine (1)Mouse (2)

  • タグ

    His Tag (5)Fc Tag (2)His Tag & Avi Tag (1)

  • マーカー

    Unconjugated (6)FITC Labeled (1)Biotin-labeled (1)

IL-13 R alpha 2バックグランド

Interleukin-13 receptor subunit alpha-2 is also known as IL13Rα2, IL13Ra2 cluster of differentiation 213A2, CD213A2, CT19, IL-13R, IL13BP, and is a membrane bound protein that in humans is encoded by the IL13RA2 gene. IL13Rα2 is closely related to IL13Rα1, a subunit of the interleukin-13 receptor complex. This protein binds IL13 with high affinity, but lacks any significant cytoplasmic domain, and does not appear to function as a signal mediator. It is, however able to regulate the effects of both IL13 and IL4, despite the fact it is unable to bind directly to the latter. It is also reported to play a role in the internalization of IL13. IL13Rα2 is a component of the cell surface receptors, however, the majority exists in intracellular pools and in soluble form, and thus plays an opposite role as a potent IL13 antagonist compared with IL13Rα1. It also functions as an inhibitor of IL4-dependent pathway probably through the physical interaction between the short intracellular domain of and cytoplasmic domain of IL13Rα2 and the IL4Rα chain. In spite of the failed STAT signaling function, IL13Rα2 dose induce TGF-beta production and fibrosis. Additionally, IL13Rα2has been reported to be abundantly and specifically overexpressed in glioblastoma multiforme.

IL-13 R alpha 2分子の別称

IL13RA2,CD213A2,CT19,IL-13R,IL13BP

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MB-101 (Mustang Bio)MB-101Phase 1 ClinicalCity Of Hope National Medical Center, Mustang Bio IncBrain Neoplasms; CNS Embryonal Tumor; Glioblastoma; Glioma
詳細
IL13Ralpha2 CAR-T cell therapy (Jonsson Comprehensive Cancer Center)Phase 1 ClinicalUclas Jonsson Comprehensive Cancer CenterAdenocarcinoma of Lung; Adenoma, Islet Cell; Adrenocortical Carcinoma; Breast Neoplasms; Ependymoma; Glioblastoma; Medulloblastoma; Melanoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Uveal melanoma
詳細
E-Sync T Cell Therapy (University of California/National Cancer Institute/California Institute for Regenerative Medicine)Phase 1 ClinicalUniversity Of California San FranciscoGlioblastoma
詳細
EPC-003EPC-003Phase 1 ClinicalElpis BioPharmaceuticals CorpGlioblastoma; Multiple Myeloma
詳細
IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody therapy (Emergency General Hospital)Phase 1 ClinicalEmergency General Hospital, Department of NeurosurgeryGlioma
詳細
IL13Rα2 targeted CAR-T cell(Yooyoung)YYB-103; CLM-103Phase 1 ClinicalYooYoung Pharmaceutical Co LtdAmyotrophic Lateral Sclerosis; Glioma
詳細
Autologous TGF-betaR2KO/IL13R-alpha2-CAR T cells Therapy(City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical CenterAstrocytoma; Glioblastoma
詳細
MT-026MT-026Phase 1 ClinicalT-Maximum Pharmaceutical (Suzhou) Co LtdGlioma
詳細
SNC-109SNC109; SNC-109Phase 1 ClinicalShanghai Simnova Biotechnology Co LtdGlioblastoma
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報